1,518
Views
13
CrossRef citations to date
0
Altmetric
Research Article

RAB40C Regulates RACK1 Stability Via the Ubiquitin–Proteasome System

, , , , , & show all
Article: FSO317 | Received 16 Feb 2018, Accepted 15 May 2018, Published online: 02 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hong Wu, Xuhui Dong, Lixian Liao & Lihaoyun Huang. (2022) An Integrative Analysis Identifying RAB40C as an Oncogenic Immune Protein and Prognostic Marker of Lung Squamous Cell Carcinoma. Pharmacogenomics and Personalized Medicine 15, pages 525-537.
Read now

Articles from other publishers (12)

Liqun Peng, Tiangen Wu, Yingyi Liu, Dongli Zhao, Wenzhi He & Yufeng Yuan. (2024) OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cellular Oncology.
Crossref
Wonseok Son, Hui Su Jeong, Da Eun Nam, Ah Jin Lee, Soo Hyun Nam, Ji Eun Lee, Byung-Ok Choi & Ki Wha Chung. (2023) Peripheral Neuropathy and Decreased Locomotion of a RAB40B Mutation in Human and Model Animals . Experimental Neurobiology 32:6, pages 410-422.
Crossref
Ruinan Tian, Jianfei Tian, Xiaoyan Zuo, Sixin Ren, He Zhang, Hui Liu, Zhiyong Wang, Yanfen Cui, Ruifang Niu & Fei Zhang. (2023) RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin. Cell Death & Disease 14:10.
Crossref
Andrew J. Neumann & Rytis Prekeris. (2023) A Rab-bit hole: Rab40 GTPases as new regulators of the actin cytoskeleton and cell migration. Frontiers in Cell and Developmental Biology 11.
Crossref
Haibin Ou, Lili Wang, Ziyao Xi, Hui Shen, Yaofei Jiang, Fuxiang Zhou, Yu Liu & Yunfeng Zhou. (2022) MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/ FAK signaling . Cancer Science 113:11, pages 3838-3851.
Crossref
Ke-Jun Han, Valeryia Mikalayeva, Scott A Gerber, Arminja N Kettenbach, Vytenis A Skeberdis & Rytis Prekeris. (2022) Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. Life Science Alliance 5:9, pages e202101346.
Crossref
Erik S. Linklater, Emily D. Duncan, Ke-Jun Han, Algirdas Kaupinis, Mindaugas Valius, Traci R. Lyons & Rytis Prekeris. (2021) Rab40–Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration. Journal of Cell Biology 220:7.
Crossref
Kexun Liu, Hongjun Huo, Wenchao Jia, Manglai Li, Zichao Xiong, Yao Sun, Jiamin Wu, Haiyue Li, Jianfeng Liu, Yuanwei Liu, Tianbo Jin, Bin Li, Yuan Zuo & Yan Zhao. (2021) RAB40C gene polymorphisms rs62030917 and rs2269556 are associated with an increased risk of lumbar disc herniation development in the Chinese Han population . The Journal of Gene Medicine 23:4.
Crossref
Selma Yilmaz Dejgaard & John F. Presley. (2021) Interactions of Lipid Droplets with the Intracellular Transport Machinery. International Journal of Molecular Sciences 22:5, pages 2776.
Crossref
Sofia Christakoudi, Manohursingh Runglall, Paula Mobillo, Irene Rebollo-Mesa, Tjir-Li Tsui, Estefania Nova-Lamperti, Catharine Taube, Sonia Norris, Yogesh Kamra, Rachel Hilton, Titus Augustine, Sunil Bhandari, Richard Baker, David Berglund, Sue Carr, David Game, Sian Griffin, Philip A. Kalra, Robert Lewis, Patrick B. Mark, Stephen D. Marks, Iain MacPhee, William McKane, Markus G. Mohaupt, Estela Paz-Artal, Sui Phin Kon, Daniel Serón, Manish D. Sinha, Beatriz Tucker, Ondrej Viklický, Daniel Stahl, Robert I. Lechler, Graham M. Lord & Maria P. Hernandez-Fuentes. (2020) Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy. EBioMedicine 58, pages 102899.
Crossref
Norihiko Ohbayashi & Mitsunori Fukuda. (2020) Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Research 9, pages 608.
Crossref
Connor M. Blair, Nicola M. Walsh, Bruce H. Littman, Frank W. Marcoux & George S. Baillie. (2019) Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf. BMC Cancer 19:1.
Crossref